News

The Mediterranean diet shows promise in managing both systemic and organ-specific autoimmune diseases, including rheumatoid ...
USC researchers have developed an innovative type of cancer-fighting immune cell, the EchoBack CAR T-cell, that uses focused ...
Researchers have uncovered a critical, previously underappreciated role for B cells in vaccine protection. Best known for producing antibodies, B cells also guide other immune cells, specifically CD8 ...
Researchers at the University of Colorado Anschutz Medical Campus have uncovered a critical, previously underappreciated role ...
Scientists from St. Jude Children's Research Hospital and the Medical College of Wisconsin have created a data science ...
The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...
Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...
Roche’s Genentech has inked a deal with Repertoire Immune Medicines aimed at discovering and developing T-cell-targeted ...
The first patient with relapsed or refractory CD5-positive T-cell lymphoma has been dosed with the CAR-T cell therapy MB-105.
A study in Nature Communications found that older cancer patients have similar outcomes with immune checkpoint inhibitors as younger patients, despite having different baseline immune profiles, ...